Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve and take on record the Audited Financial Results (Standalone and Consolidated) for quarter and financial year ended 31st March, 2025 any other business items as per the agenda circulated.

pdf

Medico Intercontinental Ltd.

22 Apr 2025

40.50

-0.83%

Company Update

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance …

BSE India

Resignation of Company Secretary and Compliance Officer w.e.f. closing hours of 22nd April, 2025.

pdf

Medico Intercontinental Ltd.

22 Apr 2025

40.50

-0.83%

Corp. Note

Medico Intercontinental Ltd - 539938 - Board Meeting Outcome for Compliances Of Regulation 30 Of SEBI …

BSE India

With reference to the subject captioned above, in compliance of the Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Ms. Puneeta Sharma, Company Secretary & Compliance Officer of the Company has tendered her resignation from the post of Company Secretary & Compliance Officer of the Company w.e.f. 22nd April, 2025, due to personal reasons. She is relieved on 22nd April, 2025 after the close of normal business hours of the Company. The additional details regarding the same is attached as Annexure - A. Please find enclosed herewith Resignation Letter submitted by Ms. Puneeta Sharma. You are requested to take the same on record. The Board Meeting of the Company commenced at 05:30 PM and concluded at 06:30 PM.

pdf

Medico Intercontinental Ltd.

08 Apr 2025

40.50

-0.83%

Corp. Note

Medico Intercontinental Ltd - 539938 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyMedico Intercontinental Ltd 2CIN NO.L24100GJ1984PLC111413 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 14.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: PUNEETA SHARMA Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: mail@medicointercontinental.com Name of the Chief Financial Officer: JAY SHARADKUMAR SHAH Designation: CHIEF FINANCIAL OFFICER EmailId: mail@medicointercontinental.cm Date: 08/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf